The Clinical Study of the Safety and Efficacy of Istaroxime in Treatment of Acute Decompensated Heart Failure

NCT02617446 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Decompensated Heart Failure

Interventions

DRUG: Placebo
DRUG: Istaroxime

Sponsor

Windtree Therapeutics